Kikuko Amagase

3.2k total citations
118 papers, 2.6k citations indexed

About

Kikuko Amagase is a scholar working on Surgery, Pharmacology and Molecular Biology. According to data from OpenAlex, Kikuko Amagase has authored 118 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 28 papers in Pharmacology and 25 papers in Molecular Biology. Recurrent topics in Kikuko Amagase's work include Helicobacter pylori-related gastroenterology studies (40 papers), Inflammatory mediators and NSAID effects (26 papers) and Gastroesophageal reflux and treatments (11 papers). Kikuko Amagase is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (40 papers), Inflammatory mediators and NSAID effects (26 papers) and Gastroesophageal reflux and treatments (11 papers). Kikuko Amagase collaborates with scholars based in Japan, Bahrain and Egypt. Kikuko Amagase's co-authors include Koji Takeuchi, Susumu Okabe, Shinichi Kato, Kenjiro Matsumoto, Hiroshi Satoh, Daichi Utsumi, Shinichi Kato, Kazuhide Higuchi, Eiji Nakamura and Shusaku Hayashi and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Kikuko Amagase

115 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kikuko Amagase Japan 30 763 672 466 356 310 118 2.6k
William T. Depew Canada 16 672 0.9× 601 0.9× 222 0.5× 353 1.0× 414 1.3× 34 3.0k
Giuseppe D’Argenio Italy 27 501 0.7× 565 0.8× 649 1.4× 168 0.5× 163 0.5× 48 2.2k
Toru Kono Japan 34 787 1.0× 606 0.9× 171 0.4× 354 1.0× 258 0.8× 159 3.0k
Shigeto Mizuno Japan 25 653 0.9× 363 0.5× 129 0.3× 396 1.1× 180 0.6× 75 1.6k
P. Sharon Israel 11 828 1.1× 559 0.8× 539 1.2× 154 0.4× 235 0.8× 19 2.6k
Webb McKnight Canada 29 1.1k 1.4× 686 1.0× 1.8k 3.8× 212 0.6× 306 1.0× 37 3.9k
Timothy S. Gaginella United States 36 831 1.1× 1.1k 1.6× 395 0.8× 207 0.6× 594 1.9× 153 3.9k
Brian K. Reuter Canada 20 730 1.0× 456 0.7× 1.1k 2.4× 85 0.2× 135 0.4× 26 2.4k
Shobha Ghosh United States 33 852 1.1× 1.7k 2.5× 265 0.6× 172 0.5× 81 0.3× 100 3.8k
Michael Dicay Canada 21 330 0.4× 640 1.0× 286 0.6× 97 0.3× 199 0.6× 26 1.9k

Countries citing papers authored by Kikuko Amagase

Since Specialization
Citations

This map shows the geographic impact of Kikuko Amagase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kikuko Amagase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kikuko Amagase more than expected).

Fields of papers citing papers by Kikuko Amagase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kikuko Amagase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kikuko Amagase. The network helps show where Kikuko Amagase may publish in the future.

Co-authorship network of co-authors of Kikuko Amagase

This figure shows the co-authorship network connecting the top 25 collaborators of Kikuko Amagase. A scholar is included among the top collaborators of Kikuko Amagase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kikuko Amagase. Kikuko Amagase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matsumoto, Misaki, Masato Katsuyama, Takeshi Okanoue, et al.. (2024). Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation. Scientific Reports. 14(1). 19288–19288. 6 indexed citations
3.
Sabt, Ahmed, Mikko Ora, Alaa El‐Din A. Bekhit, et al.. (2023). Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies. European Journal of Medicinal Chemistry. 253. 115333–115333. 19 indexed citations
4.
5.
Mohamed, Mounir A. A., Asmaa M. Kadry, Mohammed A. S. Abourehab, et al.. (2022). Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 330–342. 14 indexed citations
6.
Takeuchi, Koji & Kikuko Amagase. (2018). Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract. Current Pharmaceutical Design. 24(18). 2002–2011. 129 indexed citations
7.
8.
Amagase, Kikuko, et al.. (2014). Prophylactic Effect of Monosodium Glutamate on NSAID-Induced Enteropathy in Rats. Current Pharmaceutical Design. 20(16). 2783–2790. 11 indexed citations
9.
10.
Satoh, Hiroshi, Kikuko Amagase, & Koji Takeuchi. (2013). The Role of Food for the Formation and Prevention of Gastrointestinal Lesions Induced by Aspirin in Cats. Digestive Diseases and Sciences. 58(10). 2840–2849. 9 indexed citations
11.
Satoh, Hiroshi, Kikuko Amagase, Satomi Ebara, Yasutada Akiba, & Koji Takeuchi. (2012). Cyclooxygenase (COX)-1 and COX-2 Both Play an Important Role in the Protection of the Duodenal Mucosa in Cats. Journal of Pharmacology and Experimental Therapeutics. 344(1). 189–195. 27 indexed citations
12.
Takeuchi, Koji, et al.. (2011). Aggravation by Paroxetine, a Selective Serotonin Reuptake Inhibitor, of Antral Lesions Generated by Nonsteroidal Anti-Inflammatory Drugs in Rats. Journal of Pharmacology and Experimental Therapeutics. 338(3). 850–859. 12 indexed citations
13.
14.
Yasuda, Masashi, et al.. (2010). Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice. European Journal of Pharmacology. 650(1). 411–417. 24 indexed citations
15.
Takeuchi, Koji, Shinichi Kato, & Kikuko Amagase. (2010). Prostaglandin EP Receptors Involved in Modulating Gastrointestinal Mucosal Integrity. Journal of Pharmacological Sciences. 114(3). 248–261. 52 indexed citations
16.
Filaretova, Ludmila, et al.. (2008). Contribution of Glucocorticoids to Protective Influence of Preconditioning Mild Stress against Stress‐induced Gastric Erosions. Annals of the New York Academy of Sciences. 1148(1). 209–212. 20 indexed citations
17.
Amagase, Kikuko, et al.. (2007). Effect of dopamine on the healing of acetic acid-induced gastric ulcers in rats. Inflammopharmacology. 15(5). 209–213. 7 indexed citations
18.
Amagase, Kikuko, et al.. (2005). A novel gastric lesion model induced in rats by partial gastric vascular ligation. Inflammopharmacology. 13(1-3). 261–272. 1 indexed citations
19.
Aihara, Takeshi, Eiji Nakamura, Kikuko Amagase, et al.. (2003). Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacology & Therapeutics. 98(1). 109–127. 74 indexed citations
20.
Okabe, Shigeo, Kikuko Amagase, Hiroki Fujita, et al.. (1996). Vasoinhibitory effect of leminoprazole, a H+,K+-atpase inhibitor, on rat aortic rings. General Pharmacology The Vascular System. 27(1). 117–121. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William T. Depew Breakdown of academic impact, for papers by Giuseppe D’Argenio Breakdown of academic impact, for papers by Toru Kono Breakdown of academic impact, for papers by Shigeto Mizuno Breakdown of academic impact, for papers by P. Sharon Breakdown of academic impact, for papers by Webb McKnight Breakdown of academic impact, for papers by Timothy S. Gaginella Breakdown of academic impact, for papers by Brian K. Reuter Breakdown of academic impact, for papers by Shobha Ghosh Breakdown of academic impact, for papers by Michael Dicay
Rankless by CCL
2026